Approximately 12,000 people joined music sensation Nick Jonas and other celebrities at the Walk to Cure Diabetes hosted by JDRF’s Los Angeles Chapter (JDRF LA) on Nov. 6 at Los Angeles Dodger Stadium. The fundraising goal of the chapter is to raise more than $2 million for research toward improving the lives of every person affected by type 1 diabetes by accelerating progress on the most promising opportunities for curing, better treating, and preventing the disease.
Music sensation and actor Nick Jonas, who is also National Chairman of JDRF’s Walk to Cure Diabetes, led the crowd at the stadium. Joining Nick was Frank Buckley, JDRF LA’s Walk Grand Marshal and co-anchor of KTLA’s Emmy Award-winning signature broadcast, The KTLA Morning News, and anchor on the 1 p.m. news show.
The Walk to Cure Diabetes is JDRF LA’s biggest event every year to raise funds for diabetes research. Nationally, the annual walks raise nearly $100 million for JDRF.
“Type 1 diabetes is a disease that affects as many as 3 million Americans and it is through the help and dedication of supporters like the people joining us at the Walk that JDRF is able to fund the vital research that is already making such a difference in the lives of those affected by type 1 diabetes,” said Robert Reid, JDRF LA Executive Director. “JDRF’s Los Angeles chapter, the region’s leading fundraiser and advocate for type 1 diabetes, serves hundreds of thousands of Californians affected by this chronic and debilitating disease.” ”
JDRF LA serves Los Angeles, Ventura, Santa Barbara, San Luis Obispo, Kern, Inyo, Kings, Tulare, and Fresno counties. For more information please visit walk.jdrf.org or call (800) 533-CURE.
About Type 1 Diabetes
Type 1 diabetes is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone that enables people to get energy from food. Type 1 diabetes affects children and adults, and lasts a lifetime. As many as 3 million people in the U.S. alone are living with type 1 diabetes, and every year, more than 30,000 new cases are diagnosed – that’s 80 people per day. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump—each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
JDRF is the leading global organization focused on type 1 diabetes research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is the largest charitable supporter of diabetes research. The goal of JDRF is to improve the lives of every person affected by type 1 diabetes by accelerating progress on the most promising opportunities for curing, better treating, and preventing diabetes. JDRF collaborates with a wide spectrum of partners who share this goal. Since its founding in 1970, JDRF has awarded more than $1.5 billion to diabetes research. More than 80 percent of JDRF’s expenditures directly support research and research-related education. Past JDRF research efforts have helped to significantly improve the care of people with this disease, and have expanded the critical scientific understanding of type 1 diabetes. JDRF will not rest until type 1 diabetes is fully conquered. For more information, visit www.jdrfla.org.